A randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia
- 1 November 1996
- journal article
- clinical trial
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 30 (6) , 441-451
- https://doi.org/10.1016/s0022-3956(96)00029-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Subchronic Antidepressant Treatment with Venlafaxine or Imipramine and Effects on Blood Pressure and Heart Rate: Assessment by Automatic 24-Hour MonitoringPharmacopsychiatry, 1996
- Sertraline 50 mg daily: the optimal dose in the treatment of depressionInternational Clinical Psychopharmacology, 1995
- Long-Term Safety and Clinical Acceptability ofJournal of Clinical Psychopharmacology, 1994
- A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholiaInternational Clinical Psychopharmacology, 1994
- Progress in PsychiatryNew England Journal of Medicine, 1993
- Time course of improvement under antidepressant treatment: A survival-analytical approachEuropean Neuropsychopharmacology, 1993
- The Pharmacologic Treatment of DepressionNew England Journal of Medicine, 1991
- Biochemical, neurophysiological, and behavioral effects of Wy‐45,233 and other identified metabolites of the antidepressant venlafaxineDrug Development Research, 1991
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960